A multicultural group practicing yoga together in a bright studio

telos rx vs TMates: GLP-1 Comparison 2026

telos rx vs TMates: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated July 17, 20264 min read

Quick answer

telos rx and TMates both offer GLP-1 telehealth, but they package medication, support, and pricing differently. The right choice depends on whether you weight cost, clinical touch, or formulation flexibility highest.

Side-by-side comparison

Feature	telos rx	TMates
Best for	One integrated care team across GLP-1, hormones/longevity, sexual health, and recovery (peptide-led telehealth) rather than a single-indication weight-loss pure-play	Compounded GLP-1 with hands-on clinical touch
Medication type	Compounded semaglutide and tirzepatide (injectable, plus needle-free oral/sublingual and a microdosed tirzepatide) inside an integrated peptide-led telehealth menu; medical services by an independent US-licensed medical group (Arora Health Group)	Compounded GLP-1 with bundled clinical support
Pricing model	Cash-pay subscription with 'first month low as' intro pricing per medication; the ongoing recurring rate is NOT published on the public site (funnel-gated at start.telosrx.com), no single defensible recurring price (Oak/LIV Body mechanism)	Monthly subscription, dose-tier pricing
Semaglutide price	Compounded, advertised 'first month low as $49'; ongoing recurring rate not published (funnel-gated), confirm at enrollment	From $158/mo (compounded semaglutide, 12-month plan; $249/mo month-to-month); medication and visits included
Tirzepatide price	Compounded, injectable advertised 'first month low as $99'; oral 'first month low as $49'; microdosed 'first month low as $69'; ongoing recurring rate not published, confirm at enrollment	From $167/mo (compounded tirzepatide, 12-month plan; $297/mo month-to-month)
Key watchout	telos publishes only 'first month low as' intro figures (semaglutide $49, tirzepatide $99, oral tirzepatide $49, microdosed tirzepatide $69); the ongoing monthly rate is not shown on the public site and is confirmed inside the intake flow, confirm the real recurring price at enrollment. State availability is not published, no dispensing pharmacy is named, and shipped compounded medication is non-refundable.	The $158 headline is the compounded SEMAGLUTIDE plan (12-month term; $249/mo month-to-month). Tirzepatide costs more ($167/mo on a 12-month plan, $297 month-to-month), confirm your product and term at checkout
Price checked	Checked by a person July 17, 2026	Checked by a person July 14, 2026 · an automated check re-read it September 3, 2026

When to choose telos rx

You want one integrated care team across GLP-1 weight loss, longevity/energy (NAD+), recovery (sermorelin), and sexual health (PT-141) rather than a single-indication program
You value an upfront 'compounded / not FDA-approved' disclosure and a LegitScript-certified telehealth platform
You're comfortable confirming the real ongoing monthly price at enrollment (telos publishes only 'first month low as' intro figures)
You want async care with a 5-minute online visit and a 100% refund if a clinician decides a GLP-1 isn't the right fit

Check current telos rx pricing →

When to choose TMates

You want a compounded program with clinical check-ins built in
You'd rather pay one bundled monthly fee than line items
You want responsive messaging with prescribers
You're comfortable with a longer onboarding intake in exchange for support

Check current TMates pricing →

Full reviews

Frequently asked questions

Is telos rx cheaper than TMates?

Neither telos rx nor TMates is uniformly cheaper, both publish dose-banded and formulation-banded pricing that depends on the exact product, dose, and any insurance pathway. Compare the specific tier you'd be on at each before deciding.

Which is better for semaglutide or tirzepatide, telos rx or TMates?

Both telos rx and TMates prescribe semaglutide and tirzepatide where appropriate. Choose based on how each program handles your target medication, not just the entry price.

Are telos rx and TMates compounded or brand-name?

telos rx offers compounded semaglutide and tirzepatide (injectable, plus needle-free oral/sublingual and a microdosed tirzepatide) inside an integrated peptide-led telehealth menu; medical services by an independent us-licensed medical group (arora health group). TMates offers compounded glp-1 with bundled clinical support. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from telos rx to TMates?

Yes, switching between telos rx and TMates is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare telos rx and TMates to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Compounded, advertised 'first month low as $49'; ongoing recurring rate not published (funnel-gated), confirm at enrollment and $158/mo (compounded semaglutide, 12-month plan; $249/mo month-to-month); medication and visits included are starting tiers, not your guaranteed long-term cost.